You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 5, November 1942 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PHYTOPHARMACOLOGIC REACTIONS OF BLOOD FOLLOWING TREATMENT WITH SULFANILAMIDE AND DERIVATIVES

DAVID I. MACHT, M.D.

Arch Derm Syphilol. 1942;46(5):635-642.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cutaneous reactions are among the commonest toxic manifestations following administration of sulfanilamide and its derivatives, and as therapy with these drugs expands new toxic effects of this type are revealed. Certain of these compounds, particularly sulfathiazole,1 appear to be more liable than others to induce dermatoses. Such reactions, however, have been described as occurring after administration of all the compounds. Thus, cyanosis, jaundice, erythema and dermatitis have been observed, and even scarlatiniform, morbilliform and purpuric eruptions may develop after treatment with sulfanilamide.2 Acute exfoliative dermatitis with fatal outcome following the administration of sulfathiazole was described by Weinstein and Domm.3 Loveman and Simon4 noted erythema nodosum after sulfanilamide therapy. Vesicular eruptions were mentioned by Menville and Archinard.5 Other dermatoses occurring after sulfanilamide therapy were described by Tedder.6 Among the graver dermatologic lesions following the administration of these chemotherapeutic agents are eruptions of a pemphigoid type. . . . [Full Text PDF of this Article]


Author Affiliations

BALTIMORE

From the Pharmacological Research Laboratory, Hynson, Westcott & Dunning, Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1942 American Medical Association. All Rights Reserved.